RE.PUBLIC@POLIMI pubblicazioni di ricerca del Politecnico di Milano

PRELAJ, ARSELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.562
AS - Asia 1.836
EU - Europa 1.811
SA - Sud America 385
AF - Africa 57
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.654
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.498
RU - Federazione Russa 688
IT - Italia 637
SG - Singapore 552
CN - Cina 471
BR - Brasile 322
VN - Vietnam 270
KR - Corea 137
HK - Hong Kong 95
DE - Germania 83
FI - Finlandia 75
JP - Giappone 75
FR - Francia 70
BD - Bangladesh 65
NL - Olanda 63
GB - Regno Unito 45
CA - Canada 36
IN - India 34
AT - Austria 32
ID - Indonesia 32
IE - Irlanda 26
AR - Argentina 21
CI - Costa d'Avorio 14
ES - Italia 14
PH - Filippine 14
SE - Svezia 14
EC - Ecuador 13
IQ - Iraq 13
PL - Polonia 11
MX - Messico 10
TR - Turchia 10
UA - Ucraina 9
ZA - Sudafrica 9
CO - Colombia 8
DK - Danimarca 8
SA - Arabia Saudita 8
AZ - Azerbaigian 7
BE - Belgio 7
PK - Pakistan 7
TH - Thailandia 7
UZ - Uzbekistan 7
KG - Kirghizistan 6
MA - Marocco 6
BJ - Benin 5
CH - Svizzera 5
KE - Kenya 5
PY - Paraguay 5
TW - Taiwan 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
CZ - Repubblica Ceca 4
JM - Giamaica 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
BO - Bolivia 3
EG - Egitto 3
HN - Honduras 3
IL - Israele 3
NG - Nigeria 3
PT - Portogallo 3
SN - Senegal 3
BH - Bahrain 2
CL - Cile 2
DO - Repubblica Dominicana 2
EE - Estonia 2
HR - Croazia 2
JO - Giordania 2
KZ - Kazakistan 2
LB - Libano 2
NO - Norvegia 2
NP - Nepal 2
RS - Serbia 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
AU - Australia 1
BG - Bulgaria 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CR - Costa Rica 1
CV - Capo Verde 1
DZ - Algeria 1
ET - Etiopia 1
GE - Georgia 1
GF - Guiana Francese 1
GT - Guatemala 1
HU - Ungheria 1
IM - Isola di Man 1
IR - Iran 1
LT - Lituania 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MM - Myanmar 1
MQ - Martinica 1
MU - Mauritius 1
NA - Namibia 1
PE - Perù 1
Totale 6.651
Salva come PNG Salva come JPEG
Città #
Ashburn 461
Singapore 345
San Jose 269
Chandler 187
Milan 159
Santa Clara 156
Seoul 131
Council Bluffs 127
Hefei 115
Fairfield 105
Moscow 95
Boardman 90
Hong Kong 89
The Dalles 88
Beijing 77
Ho Chi Minh City 73
Tokyo 64
Rome 63
Helsinki 59
Hanoi 53
Los Angeles 51
Houston 49
Lauterbourg 43
Cambridge 42
Seattle 42
Wilmington 33
Woodbridge 31
Amsterdam 29
New York 28
North Charleston 27
São Paulo 27
Dublin 26
Vienna 26
Lawrence 23
Munich 23
Dallas 22
San Diego 20
Frisco 19
Buffalo 17
Kent 17
Redmond 17
Ann Arbor 16
Dong Ket 16
Naples 16
Atlanta 15
Frankfurt am Main 15
Jakarta 14
Toronto 14
Abidjan 13
Nuremberg 13
Palermo 13
Princeton 13
Da Nang 12
Las Vegas 12
Medford 12
Rio de Janeiro 12
Haiphong 11
Redwood City 10
Salt Lake City 10
Turin 10
Genoa 9
Lappeenranta 9
London 9
Salvador 9
Chicago 8
Madrid 8
Manila 8
Orem 8
Warsaw 8
Baku 7
Changsha 7
Johannesburg 7
Philadelphia 7
Stockholm 7
Tashkent 7
Turku 7
Bari 6
Bishkek 6
Chūō 6
Curitiba 6
Phoenix 6
Porto Alegre 6
Americana 5
Bologna 5
Brasília 5
Brooklyn 5
Brussels 5
Chennai 5
Copenhagen 5
Cotonou 5
Düsseldorf 5
Goiânia 5
Guangzhou 5
Guayaquil 5
Hangzhou 5
Montreal 5
Poplar 5
Tianjin 5
Zhengzhou 5
Ancona 4
Totale 3.915
Salva come PNG Salva come JPEG
Nome #
Real-world data to build explainable trustworthy artificial intelligence models for prediction of immunotherapy efficacy in NSCLC patients 257
Artificial intelligence for predictive biomarker discovery in immuno-oncology: a systematic review 250
Abstract PO-065: Artificial intelligence to improve selection for NSCLC patients treated with immunotherapy 235
Epsilon: A prognostic score for immunotherapy in advanced non-small-cell lung cancer: A validation cohort 188
APOLLO 11 Project, Consortium in Advanced Lung Cancer Patients Treated With Innovative Therapies: Integration of Real-World Data and Translational Research 186
DiM: Prognostic Score for Second- or Further-line Immunotherapy in Advanced Non–Small-Cell Lung Cancer: An External Validation 180
Data analytics for real-world data integration in TKI-treated NSCLC patients using electronic health records 177
EPSILoN: A Prognostic Score Using Clinical and Blood Biomarkers in Advanced Non–Small-cell Lung Cancer Treated With Immunotherapy 175
Choosing wisely first line immunotherapy in non-small cell lung cancer (NSCLC): what to add and what to leave out 173
Cell-free DNA from cerebrospinal fluid can be used to detect the EGFR mutation status of lung adenocarcinoma patients with central nervous system metastasis 171
ALK/ROS1 rearrangements: A real hallmark for thromboembolic events in cancer patients? 167
Relationship Between Programmed Death Receptor-Ligand 1 Expression and Response to Checkpoint Inhibitor Immunotherapy in Pulmonary Sarcomatoid Carcinoma: A Pooled Analysis 165
Efficacy and safety of immunotherapy in elderly patients with non-small cell lung cancer 162
Carcinomatosis under control by osimertinib in EGFR and TP53 mutated lung adenocarcinoma 154
178P Explainable radiomics, machine and deep learning models to predict immune-checkpoint inhibitor treatment efficacy in advanced non-small cell lung cancer patients 154
MetaLung: Towards a Secure Architecture for Lung Cancer Patient Care on the Metaverse 153
The EU-funded I3LUNG Project: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy 148
Beyond first-line immunotherapy: Potential therapeutic strategies based on different pattern progressions: Oligo and systemic progression 145
Case Report: Exceptional Response to Poziotinib in Patient with Metastatic Non-Small Cell Lung Cancer With EGFR Exon 20 Insertion Mutation 143
Immune-Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer With Uncommon Histology 141
Gastrointestinal stromal tumors and second primary malignancies: a retrospective monocentric analysis 141
The impact of decision tools during oncological consultation with lung cancer patients: A systematic review within the I3LUNG project 137
Characterization of patients with metastatic non-small-cell lung cancer obtaining long-term benefit from immunotherapy 137
PEOPLE (NTC03447678), a phase II trial to test pembrolizumab as first-line treatment in patients with advanced NSCLC with PD-L1 <50%: a multiomics analysis 135
An ensemble approach to predict immunotherapy efficacy in non-small cell lung cancer using digital pathology 132
Exploring the role of respiratory microbiome in lung cancer: A systematic review 132
Integrating clinical and biological prognostic biomarkers in patients with advanced NSCLC treated with immunotherapy: the DEMo score system 130
Evaluation of Drug-Drug Interactions in EGFR-Mutated Non-Small-Cell Lung Cancer Patients during Treatment with Tyrosine-Kinase Inhibitors 126
Circulating Fatty Acid Profile as a Biomarker for Immunotherapy in Advanced Non-Small Cell Lung Cancer 121
Treatment patterns among patients with malignant pleural mesothelioma: An Italian, population-based nationwide study 120
Immunotherapy beyond progression in patients with advanced non-small cell lung cancer 120
Prognostic role of neutrophil-to-lymphocyte ratio and EPSILoN score in advanced non-small-cell lung cancer patients treated with first-line chemo-immunotherapy 116
Isochorismatase domain-containing protein 1 (ISOC1) participates in DNA damage repair and inflammation-related pathways to promote lung cancer development 113
Systemic lupus erythematosus reactivation after chemoimmunotherapy in preexisting autoimmune disease 110
Poziotinib for EGFR and HER2 exon 20 insertion mutation in advanced NSCLC: Results from the expanded access program 109
Is there an interplay between immune checkpoint inhibitors, thromboprophylactic treatments and thromboembolic events? Mechanisms and impact in non-small cell lung cancer patients 107
Machine Learning Using Real-World and Translational Data to Improve Treatment Selection for NSCLC Patients Treated with Immunotherapy 106
Successful treatment of triple EGFR mutation T785A/L861Q/H297_E298 with afatinib 102
Novel emerging molecular targets in non-small cell lung cancer 101
The Prognostic Role of TNM Staging Compared With Tumor Volume and Number of Pleural Sites in Malignant Pleural Mesothelioma 100
Prognostic scores including peripheral blood-derived inflammatory indices in patients with advanced non-small-cell lung cancer treated with immune checkpoint inhibitors 98
Immunotherapy in advanced Non-Small Cell Lung Cancer patients with poor performance status: The role of clinical-pathological variables and inflammatory biomarkers 97
Novel patterns of progression upon immunotherapy in other thoracic malignancies and uncommon populations 95
SMO mutations confer poor prognosis in malignant pleural mesothelioma 91
Uncommon targets in non-small cell lung cancer: Everyone wants a slice of cake 86
Cost-effectiveness of first-line osimertinib informed by electronic medical records via text-mining: a real-world Italian case study of EGFR-mutated advanced NSCLC patients 67
Integrating radiomics and real-world data to predict immune checkpoint inhibitor efficacy in advanced non-small-cell lung cancer 42
Trustworthy assessment of 2D model for lung CT scans 42
Aiding data retrieval in clinical trials with large language models: The APOLLO 11 Consortium in advanced lung cancer patients 35
APOLLO11: a bio-data-driven model for clinical and translational research in lung cancer 34
Automatic Cough Analysis for Non-Small Cell Lung Cancer Detection 28
A Contrastive Variational AutoEncoder for NSCLC Survival Prediction with Missing Modalities 27
Predicting efficacy in patients with locally advanced/metastatic urothelial carcinoma (mUC) treated with immunotherapy using explainable machine learning approaches: the SamUR-AI trial on behalf of the Meet-URO group 19
Characteristics and impact of real-world evidence studies in oncology: comprehensive mapping review of publications evaluating targeted therapies in solid tumours 16
Cost-effectiveness models of non–small cell lung cancer: A systematic literature review 13
Totale 6.709
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.706
article - articoli 19.432
book - libri 0
conference - conferenze 1.274
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.412
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022267 34 27 26 11 11 27 7 17 11 12 40 44
2022/2023362 40 49 10 45 48 32 4 27 58 21 20 8
2023/2024280 13 29 12 14 11 20 7 28 29 21 19 77
2024/2025917 32 19 29 40 145 88 29 73 115 56 129 162
2025/20264.321 593 678 228 334 241 165 562 258 304 417 147 394
2026/2027113 113 0 0 0 0 0 0 0 0 0 0 0
Totale 6.709